TY - JOUR T1 - Evaluating health and well-being outcomes following the South Gloucestershire Pain Review pilot for patients on long-term opioids for chronic non-cancer pain JF - British Journal of General Practice JO - Br J Gen Pract DO - 10.3399/bjgp19X703445 VL - 69 IS - suppl 1 SP - bjgp19X703445 AU - Jo Kesten AU - Lauren Scott AU - Kevin Bache AU - Rosie Closs AU - Sabi Redwood AU - Kyla Thomas Y1 - 2019/06/01 UR - http://bjgp.org/content/69/suppl_1/bjgp19X703445.abstract N2 - Background The South Gloucestershire Pain Review pilot is an individually-tailored service to help primary care patients on long-term (>3 months) treatment with opioid painkillers for chronic non-cancer pain understand their relationship with opioids and support alternative non-drug-based pain management strategies. The pilot was based in two GP practices in South Gloucestershire.Aim To evaluate the health and well-being outcomes and perceived impact of the pilot service to inform future service development.Method Quantitative data were collected for all enrolled patients on demographics; opioid use, misuse and dose; and pre-post intervention changes in health, well-being, quality of life (QoL), pain intensity/relief, and interference with life measures. Twenty-five semi-structured interviews (18 service users, seven service providers) explored experiences of the pilot including perceived impacts.Results Fifty-nine patients were invited to use the service and 34 (58%) enrolled. The median prescribed opioid dose reduced from 90 mg (interquartile range [IQR] 60–240) at baseline to 72 mg (IQR 30–160) at follow-up (P<0.001). On average, service users showed improvement on all health, well-being, and QoL outcomes except pain relief. The service was received positively. Perceived benefits related to well-being and QoL, use of pain management strategies (for example pacing), changes in medication use and changes in primary care use.Conclusion The pilot has shown promising results. The service was viewed as acceptable and health and well-being outcomes suggest a benefit. Following further development of the service, a randomised controlled trial is needed to formally test the effects of this type of care pathway on pain management and reducing long-term opioid use. ER -